HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER WIEN
Citação
ARCHIVES OF VIROLOGY, v.161, n.8, p.2161-2168, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Next-generation sequencing (NGS) provides a practical approach to HCV complete-genome sequencing, detecting low-frequency variants and allowing analysis of viral genetic diversity (quasispecies) in the sample, and so far, it is very useful for identifying preexisting drug-resistant mutants and emerging escape mutations, as well as detecting viral recombinants containing genomic regions from different genotypes and subtypes. The aim of this study was to analyze the complete coding region of hepatitis C virus (HCV) genotype 1 (subtypes 1a and 1b) from patients with chronic infection who were direct-acting antiviral (DAA) na < ve. Next-generation sequencing (Ion Torrent (TM) PGM) was used to determine the sequence of the complete coding region of 100 HCV-monoinfected DAA-na < ve patients (51 and 49 subtypes 1a and 1b, respectively). We report the first description of nearly complete HCV genome sequences of subtype 1a and 1b isolates from a large population of Brazilian patients with chronic hepatitis C, and HCV-1a grouped in two different clades. Using this methodology, an inter-subtype 1a/1b recombinant was identified in this study.
Palavras-chave
Referências
  1. Akuta N, 2013, J CLIN MICROBIOL, V51, P2862, DOI 10.1128/JCM.01129-13
  2. Alavian SM, 2011, J VIRAL HEPATITIS, V18, P821, DOI 10.1111/j.1365-2893.2011.01530.x
  3. Calado RA, 2011, J MED VIROL, V83, P608, DOI 10.1002/jmv.21955
  4. Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056
  5. Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0
  6. Cuypers L, 2014, J VIROL METHODS, V209, P126, DOI 10.1016/j.jviromet.2014.09.009
  7. Du H, 2012, J CLIN VIROL, V54, P207, DOI 10.1016/j.jcv.2012.04.017
  8. Fan XF, 2010, METHODS MOL BIOL, V630, P139, DOI 10.1007/978-1-60761-629-0_10
  9. GARSON JA, 1990, LANCET, V336, P878, DOI 10.1016/0140-6736(90)92384-T
  10. Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006
  11. Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
  12. Hedskog C, 2015, HEPATOLOGY, V61, P471, DOI 10.1002/hep.27361
  13. Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455
  14. Kageyama S, 2006, J MED VIROL, V78, P1423, DOI 10.1002/jmv.20714
  15. Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002
  16. Lampe E, 2013, ANTIVIR THER, V18, P435, DOI 10.3851/IMP2606
  17. Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11
  18. Lee LY, 2012, INT J CLIN PRACT, V66, P342, DOI 10.1111/j.1742-1241.2012.02895.x
  19. Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658
  20. Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06
  21. Lole KS, 1999, J VIROL, V73, P152
  22. Luciani F, 2012, TRENDS BIOTECHNOL, V30, P443, DOI 10.1016/j.tibtech.2012.05.005
  23. Miura M, 2013, J VIROL, V87, P12541, DOI 10.1128/JVI.00826-13
  24. Morel V, 2016, INFECT GENET EVOL, V40, P374, DOI 10.1016/j.meegid.2015.09.030
  25. Moreno P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-203
  26. Ninomiya M, 2012, J CLIN MICROBIOL, V50, P857, DOI 10.1128/JCM.05715-11
  27. Peres-da-Silva A, 2012, MEM I OSWALDO CRUZ, V107, P254, DOI 10.1590/S0074-02762012000200016
  28. Plauzolles A, 2013, SCI WORLD J, DOI 10.1155/2013/673240
  29. Prosperi MCF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02837
  30. Ross RS, 2008, EVOL BIOINFORM, V4, P249
  31. Shi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041997
  32. Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
  33. Svarovskaia ES, 2012, J CLIN MICROBIOL, V50, P3267, DOI 10.1128/JCM.00838-12
  34. Timm J, 2007, WORLD J GASTROENTERO, V13, P4808
  35. Wyles DL, 2014, J VIRAL HEPATITIS, V21, P229, DOI 10.1111/jvh.12230
  36. Xu CH, 2012, ARCH VIROL, V157, P2153, DOI 10.1007/s00705-012-1390-z
  37. Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019
  38. Yun AB, 1996, J MED VIROL, V49, P155